Prosecution Insights
Last updated: August 14, 2026

Cytiva BioProcess R&D AB

6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (33%)
4
Medium (67%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (33%)
Double-patenting + other2 (33%)
Multi-statute (no §101)2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LI, BAO Q 1 75.5% +26.4%
GANGLE, BRIAN J 1 76.6% +15.2%
CREWS, JARET JAMES 1 43.5% +73.8%
SIFFORD, JEFFREY MARK 1 55.7% +32.1%
FAN, LYNN Y 1 47.6% +48.7%
HUANG, RYAN 1 52.4% +31.5%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18577446 METHOD FOR VIRUS CAPTURE LI, BAO Q
17905156 CHARACTERIZATION OF GENE THERAPY VECTORS SIFFORD, JEFFREY MARK

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17741394 CHROMATOGRAPHY MEDIUM FAN, LYNN Y 72d
18577446 METHOD FOR VIRUS CAPTURE LI, BAO Q
18354413 Method of Cleaning and/or Sanitizing a Separation Matrix GANGLE, BRIAN J
18260560 PURIFICATION OF POLY A-TAGGED PRODUCTS CREWS, JARET JAMES
17905156 CHARACTERIZATION OF GENE THERAPY VECTORS SIFFORD, JEFFREY MARK
14649227 Method for Cleaning of Packed Bed Chromatography Columns HUANG, RYAN

Top Art Units

Art UnitApps
1671 2
1645 1
1691 1
1759 1
1777 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18577446 METHOD FOR VIRUS CAPTURE LI, BAO Q 1671 §102§112 Non-Final OA Pending Jan 08, 2024
18354413 Method of Cleaning and/or Sanitizing a Separation Matrix GANGLE, BRIAN J 1645 §102§103§112DP Non-Final OA Pending Jul 18, 2023
18260560 PURIFICATION OF POLY A-TAGGED PRODUCTS CREWS, JARET JAMES 1691 §103 Non-Final OA Pending Jul 06, 2023
17905156 CHARACTERIZATION OF GENE THERAPY VECTORS SIFFORD, JEFFREY MARK 1671 §103§112 Final Rejection Pending Aug 26, 2022
17741394 CHROMATOGRAPHY MEDIUM FAN, LYNN Y 1759 §103DPOther Non-Final OA 72d Pending May 10, 2022
14649227 Method for Cleaning of Packed Bed Chromatography Columns HUANG, RYAN 1777 §103 Non-Final OA Pending Jun 03, 2015

Managing Cytiva BioProcess R&D AB's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month